Metraipolis › archive › dc_0ef019c05735
Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway — Europe PMC PMID:42350359
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42350359
- DOI
- 10.1038/s41419-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T08:51:14.497Z
- SHA-256 of the archived text
62ac2df618dbe38b4997b1aa370faaf1dd0118edafb991d29520304fec34a2a1- Stable URL of this page
https://metraipolis.com/documento/dc_0ef019c05735
How to cite
Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway — Europe PMC PMID:42350359 — Europe PMC (en), https://europepmc.org/article/MED/42350359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ef019c05735 (Metraipolis archive dc_0ef019c05735, sha256 62ac2df618dbe38b4997b1aa370faaf1dd0118edafb991d29520304fec34a2a1)
BibTeX
@misc{dc0ef019c05735,
title = {Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway — Europe PMC PMID:42350359},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42350359},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ef019c05735; sha256 62ac2df618dbe38b4997b1aa370faaf1dd0118edafb991d29520304fec34a2a1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42350359. Agents can read the archived copy with the MCP tool read_document.